Patents-Review.com
ClassID:

110242 ⎘

C12N2730/10171 - CPC Classification

Classification description:

Reverse transcribing DNA viruses; Details; Hepadnaviridae; Orthohepadnavirus, e.g. hepatitis B virus Demonstrated effect

Recent Application in this class:
#1
20250333450
2025-10-30

METHODS AND COMPOSITIONS FOR THE TREATMENT OF HEPATITIS B INFECTION

 #2
20250145669
2025-05-08

METHODS AND COMPOSITIONS FOR THE TREATMENT OF HEPATITIS B INFECTION

 #3
20250144202
2025-05-08

GLYCOSYL-MODIFIED FUSION PROTEIN, NUCLEIC ACID MOLECULE, EXPRESSION VECTOR, HOST CELL AND APPLICATIONS THEREOF

 #4
20240398939
2024-12-05

ADENOVIRUSES AND METHODS FOR USING ADENOVIRUSES

 #5
20240216502
2024-07-04

Universal vaccine platform

 #6
20240189353
2024-06-13

MODULATED IMMUNODOMINANCE THERAPY

 #7
20240150412
2024-05-09

Methods and compositions for the treatment of hepatitis B infection

 #8
20230090379
2023-03-23

Vaccines against hepatitis B virus

 #9
20220193230
2022-06-23

COMPOSITIONS, COMPRISING IMPROVED IL-12 GENETIC CONSTRUCTS AND VACCINES, IMMUNOTHERAPEUTICS AND METHODS OF USING THE SAME

 #10
20220016231
2022-01-20

HEPATITIS B VIRUS VACCINE AND USES THEREOF

 #11
20220002349
2022-01-06

Methods and compositions for the treatment of hepatitis B infection

 #12
20210355168
2021-11-18

CHIMERIC ANTIGEN WITH ENHANCED MULTI-IMMUNE FUNCTION THROUGH SPECIFIC BINDING TO TARGET CELL, AND USE THEREOF

 #13
20210330785
2021-10-28

Universal vaccine platform

 #14
20210002813
2021-01-07

Lipid nanoparticle vaccine adjuvants and antigen delivery systems

 #15
20200181142
2020-06-11

Derivatives And Methods Of Treating Hepatitis B Infections

 #16
20200085943
2020-03-19

Pharmaceutical composition comprising a polymeric carrier cargo complex and at least one protein or peptide antigen

 #17
20200016263
2020-01-16

Vaccines against Hepatitis B virus

 #18
20190338014
2019-11-07

Fusion peptides with antigens linked to short fragments of invariant chain(CD74)

 #19
20190336596
2019-11-07

Universal vaccine platform

 #20
20190203225
2019-07-04

GENE THERAPY FOR PATIENTS WITH FANCONI ANEMIA

 #21
20190194191
2019-06-27

Derivatives and methods of treating hepatitis B infections

 #22
20190184010
2019-06-20

Methods and apparatus for the delivery of hepatitis B virus (HBV) vaccines

 #23
20190151443
2019-05-23

Nucleic acid molecule encoding hepatitis B virus core protein and vaccine comprising the same

 #24
20190077800
2019-03-14

Derivatives and methods of treating hepatitis B infections

 #25
20190031653
2019-01-31

Derivatives and methods of treating hepatitis B infections

 #26
20180333485
2018-11-22

Compositions, comprising improved IL-12 genetic constructs and vaccines, immunotherapeutics and methods of using the same

 #27
20180243407
2018-08-30

Methods and compositions for eliciting an immune response against hepatitis B virus

 #28
20180127415
2018-05-10

Derivatives and methods of treating hepatitis B infections

 #29
20180078636
2018-03-22

Hepatitis B therapeutic vaccines

 #30
20180028635
2018-02-01

COMPOSITION AND USES THEREOF

 #31
20170216357
2017-08-03

Modulated immunodominance therapy

 #32
20170158691
2017-06-08

Derivatives and methods of treating hepatitis B infections

 #33
20170121329
2017-05-04

Derivatives and methods of treating hepatitis B infections

 #34
20170121328
2017-05-04

Derivatives and methods of treating hepatitis B infections

 #35
20170087245
2017-03-30

Methods and compositions for eliciting an immune response against hepatitis B virus

 #36
20170072035
2017-03-16

Tumor vaccination involving a humoral immune response against self-proteins

 #37
20170042998
2017-02-16

MODULATED IMMUNODOMINANCE THERAPY

 #38
20160361411
2016-12-15

Lipid nanoparticle vaccine adjuvants and antigen delivery systems

 #39
20160317652
2016-11-03

Nucleic acid molecule encoding hepatitis B virus core protein and vaccine comprising the same

 #40
20160303211
2016-10-20

DNA vaccine containing specific epitope of apolipoprotein (a)

 #41
20160235840
2016-08-18

Compositions, comprising improved Il-12 genetic constructs and vaccines, immunotherapeutics and methods of using the same

 #42
20160185779
2016-06-30

Derivatives and methods of treating hepatitis B infections

 #43
20160185778
2016-06-30

Derivatives and methods of treating hepatitis B infections

 #44
20160185777
2016-06-30

Derivatives and methods of treating hepatitis B infections

 #45
20160144011
2016-05-26

Composition and uses thereof

 #46
20160143995
2016-05-26

Method of treating intracellular infection

 #47
20160136264
2016-05-19

Hepatitis B vaccine

 #48
20160106830
2016-04-21

Vaccines against hepatitis B virus

 #49
20160008460
2016-01-14

Vaccination strategy

 #50
20150152154
2015-06-04

Tumor vaccination involving a humoral immune response against self-proteins

 #51
20150118264
2015-04-30

PHARMACEUTICAL COMPOSITION COMPRISING A POLYMERIC CARRIER CARGO COMPLEX AND AT LEAST ONE PROTEIN OR PEPTIDE ANTIGEN

 #52
20130052217
2013-02-28

Tumor vaccination involving a humoral immune response against self-proteins

 #53
20120263755
2012-10-18

Methods and compositions for eliciting an immune response against hepatitis B virus

 #54
20120087946
2012-04-12

Recombinant bacterium and methods of antigen and nucleic acid delivery